While studies had been undertaken to analyze the impact of PTEN (phosphatase and tensin homolog) alterations in bladder cancer, the broad-scale analysis in bladder cancer afforded by the Cancer Genome Atlas Project highlighted a broader role for signaling through the mTOR pathway, also in advanced disease [10,11]. Here, PTEN is linked to urinary bladder carcinoma.